Table of Contents
Chapter 1. Global AI in Predictive Toxicology Market Executive Summary
1.1. Global AI in Predictive Toxicology Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Component
1.3.2. By Technology
1.3.3. By Toxicity Endpoints
1.3.4. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global AI in Predictive Toxicology Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global AI in Predictive Toxicology Market Dynamics
3.1. Market Drivers
3.1.1. Rising investments in pharmaceutical AI startups
3.1.2. Increased demand for efficient drug development
3.1.3. Advancements in AI technologies
3.1.4. Growing need for efficient screening of chemical compounds
3.1.5. Rising concerns about chemical safety
3.2. Market Challenges
3.2.1. Insufficient or poor-quality data compromising the accuracy of predictive models
3.2.2. Complexity in the integration of AI models
3.3. Market Opportunities
3.3.1. Increasing collaborations between pharmaceutical companies and AI technology providers
3.3.2. Expansion of AI applications in predictive toxicology to other industries
3.3.3. Development of standardized protocols for AI-driven toxicity assessments
Chapter 4. Global AI in Predictive Toxicology Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global AI in Predictive Toxicology Market Size & Forecasts by Component 2022-2032
5.1. Segment Dashboard
5.2. Global AI in Predictive Toxicology Market: Solution Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Solution
5.2.1. Services
Chapter 6. Global AI in Predictive Toxicology Market Size & Forecasts by Technology 2022-2032
6.1. Segment Dashboard
6.2. Global AI in Predictive Toxicology Market: Machine Learning Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.3.1. Machine Learning
6.3.2. Natural Language Processing
6.3.3. Computer Vision
6.3.4. Others
Chapter 7. Global AI in Predictive Toxicology Market Size & Forecasts by Toxicity Endpoints 2022-2032
7.1. Segment Dashboard
7.2. Global AI in Predictive Toxicology Market: Genotoxicity Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.3.1. Genotoxicity
7.3.2. Hepatotoxicity
7.3.3. Neurotoxicity
7.3.4. Cardiotoxicity
7.3.5. Others
Chapter 8. Global AI in Predictive Toxicology Market Size & Forecasts by End User 2022-2032
8.1. Segment Dashboard
8.2. Global AI in Predictive Toxicology Market: Pharmaceutical & Biotechnology Companies Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.3.1. Pharmaceutical & Biotechnology Companies
8.3.2. Chemical & Cosmetics
8.3.3. Contract Research Organizations
8.3.4. Others
Chapter 9. Global AI in Predictive Toxicology Market Size & Forecasts by Region 2022-2032
9.1. North America AI in Predictive Toxicology Market
9.1.1. U.S. AI in Predictive Toxicology Market
9.1.1.1. By Component
9.1.1.2. By Technology
9.1.1.3. By Toxicity Endpoints
9.1.1.4. By End User
9.1.2. Canada AI in Predictive Toxicology Market
9.2. Europe AI in Predictive Toxicology Market
9.2.1. UK AI in Predictive Toxicology Market
9.2.2. Germany AI in Predictive Toxicology Market
9.2.3. France AI in Predictive Toxicology Market
9.2.4. Spain AI in Predictive Toxicology Market
9.2.5. Italy AI in Predictive Toxicology Market
9.2.6. Rest of Europe AI in Predictive Toxicology Market
9.3. Asia-Pacific AI in Predictive Toxicology Market
9.3.1. China AI in Predictive Toxicology Market
9.3.2. India AI in Predictive Toxicology Market
9.3.3. Japan AI in Predictive Toxicology Market
9.3.4. Australia AI in Predictive Toxicology Market
9.3.5. South Korea AI in Predictive Toxicology Market
9.3.6. Rest of Asia Pacific AI in Predictive Toxicology Market
9.4. Latin America AI in Predictive Toxicology Market
9.4.1. Brazil AI in Predictive Toxicology Market
9.4.2. Mexico AI in Predictive Toxicology Market
9.4.3. Rest of Latin America AI in Predictive Toxicology Market
9.5. Middle East & Africa AI in Predictive Toxicology Market
9.5.1. Saudi Arabia AI in Predictive Toxicology Market
9.5.2. South Africa AI in Predictive Toxicology Market
9.5.3. Rest of Middle East & Africa AI in Predictive Toxicology Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Benevolent AI
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Berg Health
10.3.3. Biovista
10.3.4. Celsius Therapeutics
10.3.5. Chemaxon Ltd.
10.3.6. Cyclica
10.3.7. Exscientia PLC
10.3.8. Insilico Medicine
10.3.9. Instem plc
10.3.10. Lhasa Limited
10.3.11. Recursion Pharmaceuticals
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes